United Orthopedic - Asset Resilience Ratio
United Orthopedic (4129) has an Asset Resilience Ratio of 0.13% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 4129 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2024)
This chart shows how United Orthopedic's Asset Resilience Ratio has changed over time. See United Orthopedic (4129) balance sheet quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down United Orthopedic's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 4129 stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$9.01 Million | 0.13% |
| Total Liquid Assets | NT$9.01 Million | 0.13% |
Asset Resilience Insights
- Limited Liquidity: United Orthopedic maintains only 0.13% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
United Orthopedic Industry Peers by Asset Resilience Ratio
Compare United Orthopedic's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for United Orthopedic (2020–2024)
The table below shows the annual Asset Resilience Ratio data for United Orthopedic.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.13% | NT$9.01 Million ≈ $283.71K |
NT$7.04 Billion ≈ $221.78 Million |
-0.01pp |
| 2023-12-31 | 0.14% | NT$8.89 Million ≈ $279.99K |
NT$6.42 Billion ≈ $202.17 Million |
-0.10pp |
| 2022-12-31 | 0.24% | NT$13.40 Million ≈ $422.21K |
NT$5.62 Billion ≈ $176.92 Million |
-0.27pp |
| 2020-12-31 | 0.51% | NT$28.45 Million ≈ $896.43K |
NT$5.59 Billion ≈ $176.03 Million |
-- |
About United Orthopedic
United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial kn… Read more